Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
1 other identifier
interventional
280
1 country
1
Brief Summary
Adolescents with type 1 diabetes are at increased risk for depressive symptoms, poor coping and problem-solving skills, poor regimen adherence, and negative diabetes-specific health outcomes. Although a handful of psychological interventions targeting adolescents' poor behavioral and emotional functioning demonstrate beneficial effects on disease management and outcomes, no prevention programs exist that equip adolescents with behavioral skills and cognitive strategies necessary to reduce these risks. Therefore, the proposed research will test whether a diabetes-specific adaptation of a resilience promoting, depression-prevention intervention for adolescents with type 1 diabetes will reduce both the risk of poor psychological functioning and the risk of negative health outcomes over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 7, 2011
CompletedFirst Posted
Study publicly available on registry
December 13, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedJanuary 27, 2020
January 1, 2020
4.9 years
December 7, 2011
January 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Depressive symptoms from baseline to post intervention and change in Depressive symptoms over the two year study period.
Investigators expect that Depressive symptoms will change over time. Specifically, it is expected that depressive symptoms will not increase and may even decrease in the Healthy Thinking in Teens arm, whereas depressive symptoms will increase in the Advanced Diabetes Education arm.
baseline, 4.5 months, 8.5 months, 12.5 months, 16.5 months, and 28.5 months
Secondary Outcomes (1)
Change in Glycemic Control from baseline to post-intervention and change in Glycemic Control over time during the two year study period.
baseline, 4.5 months, 8.5 months, 12.5 months, 16.5 months and 28.5 months
Study Arms (2)
Healthy Thinking in Teens
EXPERIMENTALGroup-based, manualized program, based on cognitive behavioral therapy techniques.
Advanced Diabetes Education
ACTIVE COMPARATORGroup-based, manualized program designed to provide diabetes education, focused on adolescent-specific topics.
Interventions
9 sessions. Manualized and group based program. Each session lasts 90 minutes. Sessions occur approximately every other week.
9 sessions. Manualized and group based program. Each session lasts 90 minutes. Sessions occur approximately every other week.
Eligibility Criteria
You may qualify if:
- years old,
- diagnosis of T1D according to ADA criteria for at least 1 year,
- daily insulin dosing of at least 0.5 units per kilogram per day,
- fluent in English, and
- provide assent to participate.
You may not qualify if:
- other chronic, physical disease or condition except for celiac or thyroid disease,
- diagnosis of major depressive disorder determined at screening visit,
- current treatment with an antidepressant,
- diagnosis of major mental disorder (e.g., bipolar disorder, thought disorder, anorexia nervosa),
- diagnosis of developmental disorder (e.g., mental retardation, autism, asperger's), or ward of the state.
- Adolescents must have established T1D, uncomplicated by other chronic diseases so any observed changes in glycemic control during the study cannot be attributed to other diseases or to endogenous insulin production seen in the 'honeymoon' period.28 Adolescents cannot have a diagnosis of major depressive disorder because that diagnosis warrants more intensive intervention. Further, adolescents cannot be on antidepressant medication treatment at the time they start the trial because it may impact psychological outcomes and cause unmeasured treatment effects. Finally, adolescents need to be without developmental or learning problems as that may make participation difficult, especially in a group format.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ann and Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
Related Publications (2)
Shapiro JB, Bryant FB, Holmbeck GN, Hood KK, Weissberg-Benchell J. Do baseline resilience profiles moderate the effects of a resilience-enhancing intervention for adolescents with type I diabetes? Health Psychol. 2021 May;40(5):337-346. doi: 10.1037/hea0001076.
PMID: 34152787DERIVEDHood KK, Iturralde E, Rausch J, Weissberg-Benchell J. Preventing Diabetes Distress in Adolescents With Type 1 Diabetes: Results 1 Year After Participation in the STePS Program. Diabetes Care. 2018 Aug;41(8):1623-1630. doi: 10.2337/dc17-2556. Epub 2018 Jun 19.
PMID: 29921624DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill Weissberg-Benchell, PhD
Ann & Robert H Lurie Children's Hospital of Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Psychologist, Department of Psychiatry
Study Record Dates
First Submitted
December 7, 2011
First Posted
December 13, 2011
Study Start
October 1, 2011
Primary Completion
September 1, 2016
Study Completion
March 30, 2018
Last Updated
January 27, 2020
Record last verified: 2020-01